p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.
about
Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.Aiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells.Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancerMitochondrial longevity pathwaysSuppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membraneArginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerabilitySrc tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity.p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress.Cellular functions regulated by phosphorylation of EGFR on Tyr845.Ouabain elicits human glioblastoma cells apoptosis by generating reactive oxygen species in ERK-p66SHC-dependent pathway.p66Shc couples mechanical signals to RhoA through FAK-dependent recruitment of p115-RhoGEF and GEF-H1.Heritable, allele-specific chromosomal looping between tandem promoters specifies promoter usage of SHC1.Coupled regulation by the juxtamembrane and sterile α motif (SAM) linker is a hallmark of Ephrin tyrosine kinase evolution.
P2860
Q30010278-ECCA400E-52B8-478B-ABBA-F7AA8AFBC94EQ33806421-4AC3314D-2226-4189-8187-3860132AD1C5Q34132479-008C685B-CBAE-4743-B3C6-650E9995B1CBQ34518559-B689D323-383E-459E-B7E2-8E7F514592F3Q34767374-DF2DC94B-086C-465C-BB57-5B40C0125056Q35849511-BE0B7018-1C83-4E1A-AB8B-5B4E459ADB6EQ37310506-211EDBD4-8612-46B8-96B7-40CC1AC3BD5EQ37576208-EEC581C3-124F-434C-8043-29306FA14F67Q37867129-BD18087E-ED82-4176-A2C3-B1F4C813DAF5Q38109021-25AF8CBF-7FE1-4396-B75E-BB918E4B0096Q38957007-FECDEA89-6C61-4F60-AA12-8BBAD9FFF49EQ41619834-ADF4A098-0056-4C29-9221-422021D7DFC0Q50026998-1CA10F5B-C59A-45A2-B6A6-5C83069B6A2AQ50047445-9723851C-0975-4539-838E-F528508E3A79
P2860
p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@ast
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@en
type
label
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@ast
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@en
prefLabel
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@ast
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@en
P2093
P2860
P356
P1476
p66shc inhibits insulin-like g ...... ment of Src kinase activation.
@en
P2093
David R Clemmons
Xinchun Shen
P2860
P304
P356
10.1074/JBC.M109.069872
P407
P577
2010-01-04T00:00:00Z